Envestnet Asset Management
AMAG

Envestnet Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Envestnet Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-122
Closed -$2K – 2929
2018
Q2 		$2K Hold
122
– – ﹤0.01% 2773
2018
Q1 		$2K Hold
122
– – ﹤0.01% 2745
2017
Q4 		$2K Hold
122
– – ﹤0.01% 2881
2017
Q3 		$2K Hold
122
– – ﹤0.01% 2830
2017
Q2 		$2K Sell
122
-566
-82% -$11.2K ﹤0.01% 2967
2017
Q1 		$15K Sell
688
-1,175
-63% -$28.1K ﹤0.01% 2723
2016
Q4 		$65K Sell
1,863
-859
-32% -$25.7K ﹤0.01% 2356
2016
Q3 		$67K Sell
2,722
-202
-7% -$5.05K ﹤0.01% 2495
2016
Q2 		$70K Sell
2,924
-3,274
-53% -$75.1K ﹤0.01% 2594
2016
Q1 		$145K Sell
6,198
-1,961
-24% -$46.5K ﹤0.01% 2239
2015
Q4 		$246K Sell
8,159
-2,490
-23% -$80.4K ﹤0.01% 1924
2015
Q3 		$423K Buy
10,649
+2,155
+25% +$134K ﹤0.01% 1672
2015
Q2 		$587K Buy
8,494
+3,168
+59% +$199K ﹤0.01% 1644
2015
Q1 		$291K Buy
+5,326
New +$254K ﹤0.01% 1795

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Envestnet Asset Management's AMAG Position: Q3 2018 in Review

Envestnet Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2018, closing a stake of 122 shares — an estimated $2K sold.

Envestnet Asset Management first reported a position in AMAG in Q1 2015 and held it in 14 quarters. The position peaked at $587K in Q2 2015. 182 funds tracked by Wall St. Rank hold AMAG as of Q3 2018.

  • Envestnet Asset Management reported no remaining AMAG Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Envestnet Asset Management sold 122 AMAG Pharmaceuticals shares in Q3 2018, an estimated $2K.
  • Envestnet Asset Management first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 14 quarters.
  • Envestnet Asset Management's AMAG Pharmaceuticals position peaked at $587K in Q2 2015.
  • 182 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2018.

Based on Envestnet Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.